Sort   by:  
 Page size 
UnknownClonal architecture of del(5q) myelodysplastic syndromes: aberrant CD5 or CD7 expression within the myeloid progenitor compartment defines a subset with high clonal burden.
Not available
S-EPMC4740451 | biostudies-literature
UnknownMDS-PB13 Score - Blood based detection of aberrancies by flow cytometry in patients with suspected and confirmed Myelodysplastic Neoplasms.
Not available
S-EPMC10844065 | biostudies-literature
UnknownDeep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML.
Not available
S-EPMC9198930 | biostudies-literature
UnknownAzacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial.
Not available
S-EPMC3306138 | biostudies-literature
UnknownPrognostic value of flow cytometry in myelodysplastic neoplasms (MDS): Composition of a FCM‐prognostic score (FCM‐PS) for overall survival
Not available
S-EPMC12859752 | biostudies-literature
UnknownInflammatory stromal and T cells mediate human bone marrow niche remodeling in clonal hematopoiesis and myelodysplasia.
Not available
S-EPMC12627676 | biostudies-literature
UnknownSalvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.
Not available
S-EPMC8589660 | biostudies-literature
Sort   by:  
 Page size